Elizabeth Aronson, MSN, FNP-BCN, OCN, shares what stood out to her about the phase 2 MagnetisMM-3 trial assessing elranatamab in multiple myeloma.
Elizabeth Aronson, MSN, FNP-BCN, OCN
Advertisement
Articles by Elizabeth Aronson, MSN, FNP-BCN, OCN
Elizabeth Aronson, MSN, FNP-BCN, OCN, shares what stood out to her about the phase 2 MonumenTAL-1 study assessing talquetamab in multiple myeloma.
Advertisement
Latest Updated Articles
Elizabeth Aronson Breaks Down Data From Behind Talquetamab Approval in Multiple MyelomaPublished: September 26th 2023 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
The Gift of Presence: Finding Meaning in Everyday Oncology Nursing
2
Proactively Managing Patients on IO Over Holiday Weekends and Beyond
3
FDA Approves Neo/Adjuvant Durvalumab Combo in Gastric/GEJ Adenocarcinoma
4
Multidisciplinary Team Essential to Management of Patients With mCRC
5
